In the PM session, market kept fluctuating and then stopped above yesterday level. Till market end, Electric Utility and Computer led the gain. Agriculture and Construction Material led the fall. In total, both markets traded 594.99 billion RMB, down 7.19%.
|Open||Close||% Change||(bn yuan)|
|Sector||Top 1||Led by||Top 2||Led by|
*Sinopharm inactivated coronavirus vaccine enters clinical trials
Chinese pharmaceutical company Sinopharm said one of its vaccine candidates against the SARS-CoV-2 coronavirus, which causes COVID-19 disease, has started early human trials after being given the nod for clinical trials from the country’s health authorities on Sunday.
*UN body urges China to consider grain buffer for better food security
According to the Food and Agriculture Organization of the United Nations, though China has ample stocks of grains, it must take steps to ensure the further smooth functioning of supply chains and procure enough supplies for mills and for the wholesale and retail markets.
*China approves sub-centers for overseas IP dispute mechanism
China’s National Intellectual Property Administration (NIPA) has approved the establishment of the first 10 local sub-centers across the country, to offer guidance to Chinese entities on resolving overseas intellectual property (IP) disputes.
Disclosure: Interactive Brokers
Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.
This material is from Guosen Securities Co., Ltd and is being posted with permission from Guosen Securities Co., Ltd. The views expressed in this material are solely those of the author and/or Guosen Securities Co., Ltd and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.